NuPathe Inc (fka PATH) (PATH)

[hptaxis]

I am in - 5,000 @ $2.05. In hindsight, the funding deal [NuPathe Inc Announces Common Stock Purchase Agreement For Up To $30 Million - http://www.reuters.com/finance/stocks/PATH.O/key-developments/article/2376047 ] was smart. I almost stepped in earlier, but I have a problem with the CEO salary. I feel confident for a profit from this level. This is critical to their entire existent (platform). the PR telegraphed that a phase 1 trial would be adequate, but is that the FDA opinion! I am skeptical. Regardless, they will try very hard for approval and as a consequence an increased pps.